The role of aspirin in the prevention of colorectal cancer [ 2017 - 2021 ]

Research Grant

Researchers: Prof John Zalcberg (Principal investigator) ,  A/Pr Robyn Woods ,  Prof Finlay Macrae ,  Prof Peter Gibbs ,  Prof Rory Wolfe

Brief description ASPREE is a large, phase 3 clinical study of health participants over the age of 70 years who have been randomized to either continuous low dose aspirin or placebo for an average of 5 years. This grant is concerned with collecting long-term follow-up for an additional 5 years, especially for evidence of colorectal cancer (CRC) as well as the exploration of potential mechanisms of action by which aspirin may prevent the development of CRC.

Funding Amount $AUD 1,772,544.40

Funding Scheme Project Grants

Notes Standard Project Grant